Novo Nordisk A/S (NVO) Revenue and Net Income History

Historical revenue, operating income and net income for Novo Nordisk A/S (NVO) over the last 10 years. The current TTM revenue for Novo Nordisk A/S as of December 12, 2017 is $15.98B.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $135.966B $15.976B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.